Magneto Thrombectomy Solutions

Magneto Thrombectomy Solutions is a medical device company based in Or Yehuda, Israel, focused on developing thrombectomy technologies for treating vascular occlusions caused by blood clots. Their innovative solutions address critical conditions such as pulmonary embolism, ischemic stroke, and deep vein thrombosis. The company’s core technology features positively charged catheters that attract and bind to negatively charged blood clots, facilitating their removal with minimal interaction with vessel walls. Their flagship product, the eTrieve catheter, has shown promising results in clinical studies for treating acute pulmonary embolism, demonstrating safety and significant clinical improvements. Magneto's thrombectomy solutions offer benefits like faster treatment, strong clot attachment, reduced vessel trauma, and the ability to access difficult-to-reach distal vessels. Magneto Thrombectomy Solutions is led by CEO Benny Dilmoney and a team of co-founders and experts in clinical and regulatory fields. Their primary customers include healthcare providers, hospitals, and specialized clinics focused on managing cardiovascular and neurological emergencies. The company is actively expanding its technology pipeline to address additional therapeutic areas.

• Employees 6